Skip to content
Company Analysis

BlackRock Health Sciences Term Trust BMEZ

A comprehensive view of key metrics, scores, and financial health for BlackRock Health Sciences Term Trust

Overview of BlackRock Health Sciences Term Trust

BMEZ NYQ
Financial Services Asset Management Small Cap
BlackRock Health Sciences Term Trust (BMEZ), is a Small Cap company, in the Asset Management industry, last closed at $13.95, about 49.5% overvalued vs fair value, -8.8% 1Y return, placing in the top 10% of its sector.
$13.95
-1.55%
As of March 13, 2026
Previous close • Vol 90d: 16.2%
52-Week Range
Market Cap
$871.89M
Enterprise Value
$872.10M
Overall Score
Scores locked

Create a free account to see overall and pillar scores for BlackRock Health Sciences Term Trust.

Top Beats

Quick Facts

HQ New York, NY
Fiscal year Dec 31

Next Events

Dividend Mar 13

Fair Value Snapshot

Bear Base Bull
$4
$7
$13
Current: $13.95 -50% vs base

Engine Room Money Flow™

Small Cap

Financial Services - Where revenue goes and how value is created

Flow Steps
Interest Expense
$78
Total Revenue
$24.1M
193.8%%
Operating Expense
$617.1K
56.8%%
Pre-Provision Profit
$927.2K
-89%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Financial Services

Quality & Reliability Indicators

Return on Equity
3.1%
Poor

Net Income / Equity - key bank profitability metric

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$65.5M
279.1% of Net Income

Where It Leaks

Cash Flow Health healthy
Strong cash conversion with minimal leakage across profit-to-cash-to-value chain.
Analysis based on partial data. Some metrics unavailable for complete assessment.
0
Active Leaks
0/0
Improving
0
High Impact
0
Critical
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating BlackRock Health Sciences Term Trust's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
54
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Developing
43
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

vs Industry Peers 65% Coverage
Trade-Off Triangle Visualization A ternary plot showing BMEZ's balance between Growth (33.1%), Profitability (44.7%), and Safety (22.2%). Growth 33% Safety 22% Profitability 45%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

49th percentile vs peers
50
Key Signals
Rev Growth YoY 1.94 94p EPS Growth YoY -0.9% 51p EPS CAGR 3Y -26.6% 21p Revenue CAGR 3Y -26.1% 11p
Strengths
  • Rev Growth Yoy in top 20% of peers (1.94, 94th percentile)
  • Interest Coverage Ratio in top 20% of peers ($313.2K, 98th percentile)
  • Fcf Margin in top 20% of peers (2.72, 89th percentile)
  • Consistently strong margins across 6 metrics
Risks

No significant risks identified for this axis.

Profitability

66th percentile vs peers
67
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

- vs peers
-
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for BlackRock Health Sciences Term Trust.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$7.04
- - -
-49.5% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info